# Fádi Fakhouri

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fadi-fakhouri/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,825 |
| Field | Complement system in diseases |
| h-index | 65 |
| i10-index | 154 |
| Last Known Institution | Centre Hospitalier Universitaire Vaudois |
| OpenAlex ID | https://openalex.org/A5091587971 |
| ORCID iD | 0000-0001-5390-8002 |
| Works | 335 |

## Researcher papers

Showing 12 of 15.

- [Genetics and Outcome of Atypical Hemolytic Uremic Syndrome](https://scholariq.org/papers/genetics-and-outcome-of-atypical-hemolytic-uremic-syndrome/)
- [Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/atypical-hemolytic-uremic-syndrome-and-c3-glomerulopathy-conclusions-from-a/)
- [C3 glomerulopathy: consensus report](https://scholariq.org/papers/c3-glomerulopathy-consensus-report/)
- [An international consensus approach to the management of atypical hemolytic uremic syndrome in children](https://scholariq.org/papers/an-international-consensus-approach-to-the-management-of-atypical-hemolytic/)
- [Haemolytic uraemic syndrome](https://scholariq.org/papers/haemolytic-uraemic-syndrome/)
- [Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies](https://scholariq.org/papers/use-of-eculizumab-for-atypical-haemolytic-uraemic-syndrome-and-c3/)
- [Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome](https://scholariq.org/papers/recessive-mutations-in-dgke-cause-atypical-hemolytic-uremic-syndrome/)
- [Endothelium structure and function in kidney health and disease](https://scholariq.org/papers/endothelium-structure-and-function-in-kidney-health-and-disease/)
- [Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations](https://scholariq.org/papers/pregnancy-associated-hemolytic-uremic-syndrome-revisited-in-the-era-of/)
- [C3 glomerulopathy — understanding a rare complement-driven renal disease](https://scholariq.org/papers/c3-glomerulopathy-understanding-a-rare-complement-driven-renal-disease/)
- [C3 glomerulopathy: a new classification](https://scholariq.org/papers/c3-glomerulopathy-a-new-classification/)
- [Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib](https://scholariq.org/papers/thrombotic-microangiopathy-secondary-to-vegf-pathway-inhibition-by-sunitinib/)

## Researcher topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Blood groups and transfusion](https://scholariq.org/topics/blood-groups-and-transfusion/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

## Researcher university

- [Centre Hospitalier Universitaire Vaudois](https://scholariq.org/institutions/centre-hospitalier-universitaire-vaudois/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.